Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphadenectomy and Adjuvant Chemotherapy in Thoracic Esophageal Cancer
NCT01137123Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2010
- Primary completion
- Dec 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, nedaplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Sun Yat-sen University. Started Apr 2010; status: completed.
02
Drugs
docetaxelnedaplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT01137123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01137123.